论文部分内容阅读
甲巯丙脯酸(Captopril,以下简称CPT),为一种口服血管紧张素转化酶抑制剂,用于重症、顽固性高血压、肾性高血压和难治性心力衰竭的治疗.然而其不良反应也随着使用的普遍而变得明显,有的可能致命。为提高临床使用安全度,本文就近年国内外文献报道 CPT 的不良反应予以综述,供临床使用参考。一、心血管系统的不良反应服药早期可出现低血压反应,多无症状或偶有一过性头晕、目眩及直立性低血
Captopril (CPT), an oral inhibitor of angiotensin-converting enzyme, is used in the treatment of severe, refractory hypertension, renal hypertension and refractory heart failure. However, its poor The reaction also becomes apparent with the prevalence of use, and some may be fatal. In order to improve the safety of clinical use, this article reviews the adverse reactions of CPT reported in domestic and foreign literature in recent years for clinical reference. First, the adverse reactions of the cardiovascular system Medication may occur early hypotensive reactions, asymptomatic or occasional transient dizziness, dizziness and erection of low blood